Innovation Institute
Posted on
If ever there was a time to celebrate the power of innovation, it is in the wake of the wave of innovation unleashed by the SARS CoV-2 pandemic.
At the University of Pittsburgh, taking on the world’s biggest challenges is in our DNA, and our faculty, students and staff rose to the occasion to develop innovative solutions to directly confront Covid-19. They also persevered to keep progressing on the commercial translation of their pre-pandemic discoveries.
The University of Pittsburgh Office of Innovation and Entrepreneurship presented its Celebration of Innovation on April 22, 2021, on YouTube.
The Celebration of Innovation recognizes the accomplishments of Pitt innovators who have achieved important milestones for the commercialization of their work to make an impact on the world and on people’s lives. These include being issued a patent, or having their technology or creation licensed or copyrighted, including the formation of
Monday, February 15, 2021
Share The National Academy of Inventors (NAI) this week announced it has selected three University of Pittsburgh professors among 61 academic inventors for the 2021 class of NAI senior members. They are:
Michael Lotze, professor in the Department of Surgery
Kacey Marra, professor in the Department of Plastic Surgery NAI senior members are active faculty, scientists and administrators from NAI member institutions who have demonstrated remarkable innovation producing technologies that have brought, or aspire to bring, real impact on the welfare of society. They also have growing success in patents, licensing and commercialization. “I want to congratulate Drs. Brown, Lotze and Marra on joining an exclusive society of academic inventors,” said Evan Facher, vice chancellor for innovation and entrepreneurship at Pitt and director of the Innovation Institute. “They all have demonstrated exceptional commitment to achieving impact for
Wednesday, January 27, 2021
Share
LifeX Labs, a life sciences startup incubator focused on providing early-stage companies with the support, resources and ecosystem to be successful, recently appointed Gerald J. Vardzel Jr. President and Chief Executive Officer in early January. The labs are supported in part by the University of Pittsburgh. Vardzel has extensive corporate expertise, with over 30 years of general management and commercial leadership from a broad spectrum of healthcare companies, including Fortune 500 market leaders. Over the past 20 years, he has assisted startups as well as midsize and large life science companies in developing and implementing new commercialization strategies and models for technology launches.
Thursday, November 12, 2020
Share
LifeX Labs recently announced that a new portfolio company, Duo Oncology, will be joining its Incubator program. Duo Oncology is developing ultra-small nanoparticles that can carry multiple agents deep into established tumors. The company is developing its lead product, DUO-207, for pancreatic cancer, lung cancer and other hard-to-treat tumors. The LifeX Labs Incubator program serves as a springboard for transformational startup companies in Pittsburgh and the surrounding regions through a series of curated services, affordable office and lab space, and industry and investor networks to launch and grow new ventures. LifeX Labs is supported by the University of Pittsburgh and the Henry L. Hillman Foundation.